End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.12 CNY | -2.60% | -7.48% | -47.31% |
Chart calendar DaShenLin Pharmaceutical Group Co., Ltd.
Upcoming events on DaShenLin Pharmaceutical Group Co., Ltd.
Past events on DaShenLin Pharmaceutical Group Co., Ltd.
2024-05-19 10:30 pm | Annual General Meeting |
2024-04-28 | Q4 2023 Earnings Release |
2024-04-27 | Q1 2024 Earnings Release |
2024-03-31 10:30 pm | Extraordinary Shareholders Meeting |
2024-02-07 09:30 pm | Extraordinary Shareholders Meeting |
2023-12-28 09:30 pm | Extraordinary Shareholders Meeting |
2023-10-30 | Q3 2023 Earnings Release |
2023-08-29 | Q2 2023 Earnings Release |
2023-05-18 10:30 pm | Annual General Meeting |
2023-04-27 | Q4 2022 Earnings Release |
2023-04-27 | Q1 2023 Earnings Release |
2023-04-11 10:30 pm | Extraordinary Shareholders Meeting |
2023-03-12 10:30 pm | Extraordinary Shareholders Meeting |
2023-02-02 09:30 pm | Extraordinary Shareholders Meeting |
2022-10-27 | Q3 2022 Earnings Release |
2022-08-29 | Interim 2022 Earnings Release |
2022-05-19 10:30 pm | Annual General Meeting |
2022-04-27 | Q1 2022 Earnings Release |
2022-04-27 | FY 2021 Earnings Release |
2022-03-20 10:30 pm | Extraordinary Shareholders Meeting |
Past dividends on DaShenLin Pharmaceutical Group Co., Ltd.
2024-06-20 | Annual 0.31 CNY |
2023-06-08 | Annual 0.6 CNY |
2022-06-12 | Annual 0.5 CNY |
2021-06-09 | Annual 0.8 CNY |
2020-06-16 | Annual 0.6 CNY |
2019-05-29 | Annual 0.6 CNY |
2018-06-18 | Annual 0.6 CNY |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 11 141 11 059 0.74% | 14 583 14 501 0.57% | 16 759 17 442 -3.91% | 21 248 20 468 3.81% | 24 531 24 720 -0.76% | 29 398 |
EBITDA Million CNY | Released Forecast Spread | 1 211 947 27.87% | 1 788 1 660 7.67% | 2 408 1 775 35.63% | 1 883 2 263 -16.81% | 2 119 2 532 -16.31% | 3 110 |
EBIT Million CNY | Released Forecast Spread | 918 914 0.5% | 1 448 1 415 2.35% | 1 041 1 452 -28.35% | 1 421 1 493 -4.85% | 1 632 1 868 -12.66% | 2 077 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 919 914 0.63% | 1 446 1 421 1.81% | 1 044 1 469 -28.94% | 1 415 1 477 -4.18% | 1 628 1 807 -9.91% | 1 956 |
Net income Million CNY | Released Forecast Spread | 703 671 4.67% | 1 062 1 058 0.39% | 791 1 093 -27.58% | 1 036 1 098 -5.65% | 1 166 1 303 -10.51% | 1 404 |
EPS CNY | Released Forecast Spread | 0,61 0,67 -8.96% | 0,94 0,93 0.42% | 0,69 1,00 -30.62% | 0,91 0,98 -7.38% | 1,03 1,15 -10.59% | 1,23 |
Announcement Date | 28/04/20 | 19/04/21 | 27/04/22 | 27/04/23 | 28/04/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 4 677 4 986 -6.21% | 5 044 4 705 7.21% | 5 097 5 231 -2.56% | 6 430 5 872 9.51% | 5 947 5 929 0.31% | 6 045 6 350 -4.8% | 5 731 6 269 -8.57% | 6 808 6 760 0.71% | 6 752 6 842 -1.32% | 7 220 | 7 275 | 8 317 | 8 351 | 9 135 |
EBITDA Million CNY | Released Forecast Spread | 614 579 5.99% | 499 681 -26.83% | 427 703 -39.25% | 654 | 891 | 864 | 796 | 547 | 571 930 -38.59% | 953 | 953 | 856 | 1 000 | 1 051 |
EBIT Million CNY | Released Forecast Spread | 492 452 9% | 439 410 7.07% | 292 | 198 246 -19.67% | 684 574 19.19% | 577 544 5.95% | 372 419 -11.39% | 27,4 182 -84.89% | 571 541 5.61% | 618 | 504 | 338 | 579 | 633 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 494 418 18.07% | 443 306 44.93% | 289 325 -11.33% | 189 301 -37.31% | 679 461 47.28% | 547 472 15.86% | 364 397 -8.36% | 37,5 165 -77.35% | 572 509 12.27% | 498 | 498 | 424 | 564 | 613 |
Net income Million CNY | Released Forecast Spread | 384 308 24.88% | 330 227 45.61% | 209 241 -13.28% | 112 214 -47.36% | 497 341 45.78% | 421 342 22.95% | 257 271 -5.25% | -7,86 97,3 -108.08% | 398 470 -15.22% | 357 | 357 | 315 | 404 | 439 |
EPS CNY | Released Forecast Spread | 0,34 0,28 21.1% | 0,28 0,25 16.07% | 0,18 | 0,10 0,17 -40.51% | 0,43 0,43 -0% | 0,38 0,37 2.05% | 0,22 0,22 1.84% | 0,35 0,10 255.4% | 0,35 0,32 10.79% | 0,38 | 0,33 | 0,17 | 0,34 | 0,36 |
Announcement Date | 27/04/22 | 29/08/22 | 27/10/22 | 27/04/23 | 27/04/23 | 29/08/23 | 30/10/23 | 28/04/24 | 28/04/24 | - | - | - | - | - |
Past sector events for DaShenLin Pharmaceutical Group Co., Ltd.
2024-07-10 | DOCMORRIS AG: Q2 2024 Sales and Revenue Release - Trading Update |
2024-07-07 | WELCIA HOLDINGS CO., LTD.: Q1 2024 Earnings Release |
2024-07-03 | WELCIA HOLDINGS CO., LTD.: Q1 2024 Earnings Release (Projected) |
2024-06-27 07:00 am | WALGREENS BOOTS ALLIANCE, INC.: Q3 2024 Earnings Release |
2024-06-19 | SOPHARMA AD: May 2024 Sales and Revenue Release |
2024-05-31 01:05 am | DIS-CHEM PHARMACIES LIMITED: Q4 2024 Earnings Release |
2024-05-29 | SOPHARMA AD: Q1 2024 Earnings Release |
2024-05-28 06:51 am | MEDPLUS HEALTH SERVICES LIMITED: Q4 2024 Earnings Release |
2024-05-26 | ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED: Q4 2024 Earnings Release |
2024-05-19 | SOPHARMA AD: April 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603233 Stock
- Calendar DaShenLin Pharmaceutical Group Co., Ltd.